Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical and Cord Blood Transplant in Hematologic Malignancies
NCT01050946Phase 2Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Jul 2009
- Primary completion
- Mar 2013
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
Phase 2, open-label trial of Haplo-cord HCT in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and 6 more, sponsored by Medical College of Wisconsin. Started Jul 2009; status: terminated.
02
Drugs
Haplo-cord HCT
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic lymphocytic leukemia (CLL)chronic myeloid leukemia (CML)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01050946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050946.